|1.||Bodell, William J: 2 articles (02/2009 - 01/2003)|
|2.||Lee, Jae Min: 1 article (12/2015)|
|3.||Choi, In Young: 1 article (12/2015)|
|4.||Yim, Hyung Joon: 1 article (12/2015)|
|5.||Jung, Young Kul: 1 article (12/2015)|
|6.||Yeom, Suk Keu: 1 article (12/2015)|
|7.||Lee, Sang Woo: 1 article (12/2015)|
|8.||Kim, Seung Young: 1 article (12/2015)|
|9.||Hyun, Jong Jin: 1 article (12/2015)|
|10.||Koo, Ja Seol: 1 article (12/2015)|
05/01/1999 - "In a preliminary experiment, a single intratumoral injection of AdMLPvp3 into a xenogeneic tumor (HepG2 cells in Balb/Cnu/nu mice) resulted in a significant reduction of tumor growth. "
08/15/1997 - "The results provide clear evidence that MGMT exerts protection against CNU-induced cancer. "
01/14/1999 - "The MGMT gene is highly regulated in mammalian cells and its overexpression, observed in many types of tumor cells, is often associated with cellular resistance to CNU. "
06/01/1988 - "These results suggest that O6-alkylguanine-DNA-alkyltransferase (O6-AT) plays an important role in determining the cytotoxicity of and the induction of SCEs by CNU in both rodent and human tumor cells. "
03/01/1985 - "In the present study we have examined whether or not conditions which inhibit the ability of a cell to prevent CNU-induced DNA interstrand crosslinking can also prevent DNA interstrand crosslinking induced by four clinically used alkylating anti-tumor agents. "
|2.||Melanoma (Melanoma, Malignant)
02/01/2009 - "There was a significant correlation between CNU LD(10) values and with the levels of levels of N7-bis-G and N1-HOEtdG (R = -0.91, P = 0.01) and dG-dC crosslink (R = -0.94, P = 0.005) in the glioma cell lines. "
02/01/2009 - "The levels of N7-HOEtG, N7-ClEtG; O(6)-HOEtdG and PTE were not significantly different in the glioma lines and their levels were not associated with the induction of cytotoxicity by CNU treatment. "
09/01/1986 - "The subclone morphologically resembled its CNU-sensitive parental glioma cell strain. "
01/01/1991 - "Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. "
12/01/2005 - "A multi-centre phase II study of SarCNU-a novel chloroethylnitrosourea (CNU)-in patients with recurrent malignant glioma to assess response rate, survival and effects of treatment. "
|4.||Breast Neoplasms (Breast Cancer)
03/17/1995 - "These results for the first time emphasize the predictive role of AGT in selecting the responder patients by AGT determination in breast tumor biopsies and further encourage therapeutic trials based on biochemical modulation of CNU resistance against malignant cells."
10/01/1987 - "Specific binding to ER in the cytosol of MCF-7 human breast cancer cells was demonstrated in these conjugates: 17 alpha-CNU greater than 17 beta-CNU greater than HEX-CNU greater than lomustine (CCNU). "
01/01/2007 - "X-ray radiography revealed that systemic Ki26894 treatment initiated 1 day before the inoculation of MDA-231-D cells into the left ventricle of BALB/cnu/nu female mice resulted in decreased bone metastasis of breast cancer cells. "
01/01/1983 - "In the present study we have measured the CNU-induced DNA interstrand crosslinking in IMR-90 normal human fibroblasts (Mer+), HT-29 human colon carcinoma cells (Mer+), and VA-13 SV-40 transformed human cells (Mer-) following pretreatment with MNNG. "
01/01/1984 - "We wish to report that pretreatment of Mer+ cells (HT-29 human colon carcinoma cells and IMR-90 normal human fibroblasts) with the DNA methylating agent MNNG, under conditions which should inactivate O6-methyl-transferase, apparently saturates the monoadduct repair system, and allows CNU to form interstrand crosslinks in these cells. "
|6.||DNA (Deoxyribonucleic Acid)
|9.||2- ((((2- chloroethyl)nitrosoamino)carbonyl)amino)propanamide (SarCNU)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)